BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 15953931)

  • 1. Evolution of antifungal-drug resistance: mechanisms and pathogen fitness.
    Anderson JB
    Nat Rev Microbiol; 2005 Jul; 3(7):547-56. PubMed ID: 15953931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population dynamics and the evolution of antifungal drug resistance in Candida albicans.
    Huang M; Kao KC
    FEMS Microbiol Lett; 2012 Aug; 333(2):85-93. PubMed ID: 22540673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.
    Sanglard D; Coste A; Ferrari S
    FEMS Yeast Res; 2009 Oct; 9(7):1029-50. PubMed ID: 19799636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.
    Cowen LE
    Nat Rev Microbiol; 2008 Mar; 6(3):187-98. PubMed ID: 18246082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of drug resistance in Candida albicans.
    Cowen LE; Anderson JB; Kohn LM
    Annu Rev Microbiol; 2002; 56():139-65. PubMed ID: 12142485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug susceptibilities of yeast cells are affected when expressing mutant Candida albicans drug resistance protein.
    Gao PH; Cao YB; Jia XM; Cao YY; Quan H; Wang Y; Jiang YY
    Int J Antimicrob Agents; 2006 Jul; 28(1):69-74. PubMed ID: 16782311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):490-8. PubMed ID: 9011208
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy.
    Shingu-Vazquez M; Traven A
    Eukaryot Cell; 2011 Nov; 10(11):1376-83. PubMed ID: 21926328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms influencing the evolution of resistance to Qo inhibitor fungicides.
    Gisi U; Sierotzki H; Cook A; McCaffery A
    Pest Manag Sci; 2002 Sep; 58(9):859-67. PubMed ID: 12233175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemistry of azole derivatives and the problem of drug resistance].
    Kerridge D; Parker S
    Ann Dermatol Venereol; 1989; 116 Suppl 1():7-9. PubMed ID: 2688527
    [No Abstract]   [Full Text] [Related]  

  • 11. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
    Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
    Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Evolution of Antifungal Drug Resistance.
    Robbins N; Caplan T; Cowen LE
    Annu Rev Microbiol; 2017 Sep; 71():753-775. PubMed ID: 28886681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of medically important fungi.
    Whelan WL
    Crit Rev Microbiol; 1987; 14(2):99-170. PubMed ID: 3549159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.
    Mai A; Rotili D; Massa S; Brosch G; Simonetti G; Passariello C; Palamara AT
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1221-5. PubMed ID: 17196388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell biology. A fungal Achilles' heel.
    Heitman J
    Science; 2005 Sep; 309(5744):2175-6. PubMed ID: 16195450
    [No Abstract]   [Full Text] [Related]  

  • 16. Two mutants selectively resistant to polyenes reveal distinct mechanisms of antifungal activity by nystatin and amphotericin B.
    Hapala I; Klobucníková V; Mazánová K; Kohút P
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1206-9. PubMed ID: 16246082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting virulence: a new paradigm for antifungals.
    Gauwerky K; Borelli C; Korting HC
    Drug Discov Today; 2009 Feb; 14(3-4):214-22. PubMed ID: 19152839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
    Kurnatowski P; Makieło L; Horwatt-Bozyczko E
    Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and fungicidal activity of 3,5-dichloropyrazin-2(1H)-one derivatives.
    François IE; Cammue BP; Bresseleers S; Fleuren H; Hoornaert G; Mehta VP; Modha SG; Van der Eycken EV; Thevissen K
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4064-6. PubMed ID: 19556127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal resistance in Cambodian children with acquired immunodeficiency syndrome.
    Krcmery V; Augustinova A; Babelova O; Doczeova A; Liskova A
    Pediatr Infect Dis J; 2006 May; 25(5):470. PubMed ID: 16645523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.